Cargando…
Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia
Neddylation is a sequential enzyme-based process which regulates the function of E3 Cullin-RING ligase (CRL) and thus degradation of substrate proteins. Here we show that CD8(+) T cells are a direct target for therapeutically relevant anti-lymphoma activity of pevonedistat, a Nedd8-activating enzyme...
Autores principales: | Wang, Xiaoguang, Chen, Canping, Vuong, Dan, Rodriguez-Rodriguez, Sonia, Lam, Vi, Roleder, Carly, Wang, Jing H., Kambhampati, Swetha, Berger, Allison, Pennock, Nathan, Torka, Pallawi, Hernandez-Ilizaliturri, Francisco, Siddiqi, Tanya, Wang, Lili, Xia, Zheng, Danilov, Alexey V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244170/ https://www.ncbi.nlm.nih.gov/pubmed/37031300 http://dx.doi.org/10.1038/s41375-023-01889-x |
Ejemplares similares
-
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
por: Torka, Pallawi, et al.
Publicado: (2023) -
Pevonedistat, a NEDD8‐activating enzyme inhibitor, induces apoptosis and augments efficacy of chemotherapy and small molecule inhibitors in pre‐clinical models of diffuse large B‐cell lymphoma
por: Torka, Pallawi, et al.
Publicado: (2020) -
Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
por: Goel, Shipra, et al.
Publicado: (2022) -
EPS reinvigorated
Publicado: (1973) -
Reinvigorating electrochemistry education
por: Kempler, Paul A., et al.
Publicado: (2021)